UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Excess Ticagrelor Mortality: Reporting Bias or a Canary in the Coal Mine?

The American journal of medicine, 2017-08, Vol.130 (8), p.e351-e351

Hauch, Ole

2017

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results from the PLATO study

European heart journal, 2013-01, Vol.34 (3), p.220-228

2013

Link zum Volltext

Verfügbarkeit prüfen

A new instrument for measuring anticoagulation-related quality of life: development and preliminary validation

Health and quality of life outcomes, 2004-05, Vol.2 (1), p.22-22

2004

Link zum Volltext

Verfügbarkeit prüfen

Factors influencing physicians' reported use of anticoagulation therapy in nonvalvular atrial fibrillation: A cross-sectional survey

Clinical therapeutics, 2003-06, Vol.25 (6), p.1750-1764

2003

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA Trial

Journal of clinical oncology, 2020-08, Vol.38 (24), p.2773-2781

2020

Link zum Volltext

Verfügbarkeit prüfen

A Validation Study of the Rank-Preserving Structural Failure Time Model: Confidence Intervals and Unique, Multiple, and Erroneous Solutions

Medical decision making, 2018-05, Vol.38 (4), p.509-519

2018

Link zum Volltext

Verfügbarkeit prüfen

Therapies for acute myeloid leukemia in patients ineligible for standard induction chemotherapy: a systematic review

Future oncology (London, England), 2023-04, Vol.19 (11), p.789-810

2023

Link zum Volltext

Verfügbarkeit prüfen

One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database

Current medical research and opinion, 2008-02, Vol.24 (2), p.461-468

2008

Link zum Volltext

Verfügbarkeit prüfen

A UK cost–effectiveness analysis of trifluridine/tipiracil for heavily pretreated metastatic gastroesophageal cancers

Future oncology (London, England), 2023-03, Vol.19 (9), p.643-650

2023

Link zum Volltext

Verfügbarkeit prüfen

Warfarin Anticoagulation and Outcomes in Patients With Atrial Fibrillation

Chest, 2004-12, Vol.126 (6), p.1938-1945

2004

Link zum Volltext

Verfügbarkeit prüfen

Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed

Current medical research and opinion, 2009-12, Vol.25 (12), p.2853-2864

2009

Link zum Volltext

Verfügbarkeit prüfen

Quality of anticoagulation monitoring in nonvalvular atrial fibrillation patients: comparison of anticoagulation clinic versus usual care

The Annals of pharmacotherapy, 2008-01, Vol.42 (1), p.62

2008

Link zum Volltext

Verfügbarkeit prüfen

Letter--Prudent Formulary Management or Underutilization of the Novel P2Y12 Receptor Inhibitors in Patients with Acute Coronary Syndrome Who Received Percutaneous Coronary Intervention?

Journal of managed care & specialty pharmacy, 2017-05, Vol.23 (5), p.598

Hauch, Ole

2017

Link zum Volltext

Verfügbarkeit prüfen

Warfarin exposure and the risk of thromboembolic and major bleeding events among medicaid patients with atrial fibrillation

The Annals of pharmacotherapy, 2006-06, Vol.40 (6), p.1024

2006

Link zum Volltext

Verfügbarkeit prüfen

Treatment patterns and real-world effectiveness of warfarin in nonvalvular atrial fibrillation within a managed care system

Current medical research and opinion, 2005-10, Vol.21 (10), p.1583-1594

2005

Link zum Volltext

Verfügbarkeit prüfen

Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study

The Annals of pharmacotherapy, 2005-03, Vol.39 (3), p.446

2005

Link zum Volltext

Verfügbarkeit prüfen

Frequency of Concurrent Use of Warfarin with Potentially Interacting Drugs

Pharmacotherapy, 2004-12, Vol.24 (12), p.1668-1674

2004

Link zum Volltext

Verfügbarkeit prüfen

Incidence of death and recurring acute coronary syndrome after stopping clopidogrel therapy in a large commercially-insured population in the US

Current medical research and opinion, 2011-06, Vol.27 (6), p.1079-1087

2011

Link zum Volltext

Verfügbarkeit prüfen

Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting

Clinical therapeutics, 2004-07, Vol.26 (7), p.1149-1159

2004

Link zum Volltext

Verfügbarkeit prüfen

Monitoring anticoagulation in atrial fibrillation

Journal of thrombosis and thrombolysis, 2006-04, Vol.21 (2), p.191-198

2006

Link zum Volltext

Verfügbarkeit prüfen

An Evaluation of the Impact of Recurrent Venous Thromboembolic Disease and Hemorrhagic Events within the Managed Care Setting

Blood, 2004-11, Vol.104 (11), p.2207-2207

2004

Link zum Volltext

Verfügbarkeit prüfen

Economic and Utilization Outcomes Associated with Choice of Treatment for Venous Thromboembolism in Hospitalized Patients

Value in health, 2005-05, Vol.8 (3), p.191-200

2005

Link zum Volltext

Verfügbarkeit prüfen

Economic Implications of Extended-Release Metoprolol Succinate for Heart Failure in the MERIT-HF Trial: A US Perspective of the MERIT-HF Trial

Journal of cardiac failure, 2005-12, Vol.11 (9), p.647-656

2005

Link zum Volltext

Verfügbarkeit prüfen

International Normalized Ratio (INR) Monitoring in Patients with Recurrent Venous Thromboembolism (VTE): Opportunity for Improvement in Quality of Management?

Blood, 2004-11, Vol.104 (11), p.2202-2202

2004

Link zum Volltext

Verfügbarkeit prüfen

Biologic Tolerance of Two Different Low Molecular Weight Heparins

Seminars in thrombosis and hemostasis, 1991-10, Vol.17 (4), p.450-454

1991

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(30)
Buchkapitel
(1)

Sprache

Englisch
(31)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Excess Ticagrelor Mortality: Reporting Bias or a Canary in the Coal Mine?

Cost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results from the PLATO study

A new instrument for measuring anticoagulation-related quality of life: development and preliminary validation

Factors influencing physicians' reported use of anticoagulation therapy in nonvalvular atrial fibrillation: A cross-sectional survey

Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA Trial

A Validation Study of the Rank-Preserving Structural Failure Time Model: Confidence Intervals and Unique, Multiple, and Erroneous Solutions

Therapies for acute myeloid leukemia in patients ineligible for standard induction chemotherapy: a systematic review

One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database

A UK cost–effectiveness analysis of trifluridine/tipiracil for heavily pretreated metastatic gastroesophageal cancers

Warfarin Anticoagulation and Outcomes in Patients With Atrial Fibrillation

Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed

Quality of anticoagulation monitoring in nonvalvular atrial fibrillation patients: comparison of anticoagulation clinic versus usual care

Letter--Prudent Formulary Management or Underutilization of the Novel P2Y12 Receptor Inhibitors in Patients with Acute Coronary Syndrome Who Received Percutaneous Coronary Intervention?

Warfarin exposure and the risk of thromboembolic and major bleeding events among medicaid patients with atrial fibrillation

Treatment patterns and real-world effectiveness of warfarin in nonvalvular atrial fibrillation within a managed care system

Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study

Frequency of Concurrent Use of Warfarin with Potentially Interacting Drugs

Incidence of death and recurring acute coronary syndrome after stopping clopidogrel therapy in a large commercially-insured population in the US

Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting

Monitoring anticoagulation in atrial fibrillation

An Evaluation of the Impact of Recurrent Venous Thromboembolic Disease and Hemorrhagic Events within the Managed Care Setting

Economic and Utilization Outcomes Associated with Choice of Treatment for Venous Thromboembolism in Hospitalized Patients

Economic Implications of Extended-Release Metoprolol Succinate for Heart Failure in the MERIT-HF Trial: A US Perspective of the MERIT-HF Trial

International Normalized Ratio (INR) Monitoring in Patients with Recurrent Venous Thromboembolism (VTE): Opportunity for Improvement in Quality of Management?

Biologic Tolerance of Two Different Low Molecular Weight Heparins

Suchergebnisse filtern